Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines
Will partner with innovators to unlock their manufacturing potential by capitalizing on best-in-class manufacturing technologies and bioprocessing expertise
Crucell N.V. is acquiring Xcellerex, Inc.'s FlexFactory bioproduction line and multiple XDR single-use bioreactors as part of its effort to expand capacity and flexibility of its manufacturing capabilities.